Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Clinical Chemistry Uppsala University, Uppsala, Sweden.
Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.
Curr Res Transl Med. 2022 May;70(2):103323. doi: 10.1016/j.retram.2021.103323. Epub 2021 Dec 31.
Extracellular vesicles (EVs) derived exogenously from pluripotent stem cells or endogenously from healthy human serum exert cardioprotective effects after injury. However role of endogenous EVs from myocardial infarction (MI) patients not well understood in this settings.
The EVs from plasma of MI patients with preserved or reduced left ventricular ejection fraction (LVEF) and healthy controls (HC) were purified and characterized by flow cytometry, mass spectrometry (MS) and transmission electron microscopy (TEM). HCM and human cardiac microvascular endothelial cells (hCMVECs), under individual culture or co-culture, were used to study functional effects of EVs upon TNFα stimulation. These effects of EVs on HCM and hCMVECs were observed using cell death assays, western blots and confocal microscopy. Higher concentrations of platelet-, leukocyte-, endothelial- and erythrocyte-derived EVs were found in MI patients, both with preserved and reduced LVEF, compared to HC, and MS data on MI EVs proteome displayed alteration in several proteins. MI EVs protected HCM and hCMVECs against staurosporine-induced apoptosis. Furthermore, MI EVs were observed to abrogate TNFα-triggered HCM and hCMVECs death under both individually cultured and co-cultured conditions. MI EVs failed to inhibit TNFα induced hCMVECs and HCM activation when cultured individually, however co-cultured hCMVECs with HCM supported MI EVs capacity to attenuate TNFα induced cells activation. MI CD41+ EVs but not HC EVs were found to be internalized by HCM directly or migrated through hCMVECs to HCM. MI EVs indirectly restores TNFα mediated drop in mitochondrial membrane potential.
Endogenous EVs from MI patients, regardless of severity of the MI exert cardioprotective potential upon TNFα-induced cell death. Patient-derived EVs needs to be further explored to elucidate their potential cardioprotective role during MI.
来源于多能干细胞的外泌体(EVs)或来源于健康人血清的内源性 EVs 在损伤后发挥心脏保护作用。然而,在这种情况下,来自心肌梗死(MI)患者的内源性 EVs 的作用尚不清楚。
从射血分数保留或降低的 MI 患者和健康对照者(HC)的血浆中纯化和表征 EVs,通过流式细胞术、质谱(MS)和透射电子显微镜(TEM)。单独培养或共培养的 HCM 和人心肌微血管内皮细胞(hCMVEC)用于研究 EVs 在 TNFα刺激下对 HCM 和 hCMVEC 的功能影响。通过细胞死亡测定、western blot 和共聚焦显微镜观察 EVs 对 HCM 和 hCMVEC 的这些影响。与 HC 相比,在射血分数保留或降低的 MI 患者中,血小板、白细胞、内皮细胞和红细胞衍生的 EVs 的浓度更高,并且 MS 数据显示 MI EVs 蛋白质组中的几种蛋白质发生了改变。MI EVs 可保护 HCM 和 hCMVEC 免受 staurosporine 诱导的凋亡。此外,在单独培养和共培养条件下,MI EVs 可阻止 TNFα触发的 HCM 和 hCMVEC 死亡。然而,当单独培养时,MI EVs 未能抑制 TNFα诱导的 hCMVEC 和 HCM 激活,但与 hCMVEC 共培养的 HCM 支持 MI EVs 减轻 TNFα诱导的细胞激活的能力。发现 MI CD41+EVs 而不是 HC EVs 可被 HCM 直接内化或通过 hCMVEC 迁移到 HCM。MI EVs 间接恢复 TNFα 介导的线粒体膜电位下降。
无论 MI 的严重程度如何,来自 MI 患者的内源性 EVs 在 TNFα 诱导的细胞死亡时都具有心脏保护潜力。需要进一步探索患者来源的 EVs,以阐明它们在 MI 期间的潜在心脏保护作用。